Sarika Wairkar

3.1k total citations
86 papers, 2.3k citations indexed

About

Sarika Wairkar is a scholar working on Pharmaceutical Science, Molecular Biology and Biomaterials. According to data from OpenAlex, Sarika Wairkar has authored 86 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Pharmaceutical Science, 20 papers in Molecular Biology and 14 papers in Biomaterials. Recurrent topics in Sarika Wairkar's work include Advanced Drug Delivery Systems (18 papers), Advancements in Transdermal Drug Delivery (16 papers) and Drug Solubulity and Delivery Systems (13 papers). Sarika Wairkar is often cited by papers focused on Advanced Drug Delivery Systems (18 papers), Advancements in Transdermal Drug Delivery (16 papers) and Drug Solubulity and Delivery Systems (13 papers). Sarika Wairkar collaborates with scholars based in India and Argentina. Sarika Wairkar's co-authors include Ram Gaud, Yogesh A. Kulkarni, Vinay Sridhar, Bala Prabhakar, Amrita Bajaj, Ritu Jain, Lokesh Kumar Bhatt, Anju Sharma, Mónica Cristina García and Soji Soman and has published in prestigious journals such as Brain Research, Journal of Controlled Release and International Journal of Pharmaceutics.

In The Last Decade

Sarika Wairkar

83 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarika Wairkar India 25 598 565 464 410 290 86 2.3k
Jie Tang China 25 1.1k 1.8× 435 0.8× 390 0.8× 320 0.8× 149 0.5× 83 2.6k
Alam Zeb Pakistan 31 1.0k 1.7× 1.1k 2.0× 869 1.9× 596 1.5× 294 1.0× 66 3.3k
Khalid M. El‐Say Saudi Arabia 25 557 0.9× 987 1.7× 628 1.4× 494 1.2× 224 0.8× 77 2.3k
Omer Salman Qureshi Pakistan 17 668 1.1× 734 1.3× 711 1.5× 505 1.2× 265 0.9× 25 2.1k
Swarnlata Saraf India 26 962 1.6× 1.6k 2.9× 853 1.8× 491 1.2× 198 0.7× 50 3.5k
Hidemasa Katsumi Japan 35 957 1.6× 1.4k 2.5× 335 0.7× 333 0.8× 148 0.5× 116 3.1k
Ferenc Fenyvesi Hungary 26 665 1.1× 649 1.1× 336 0.7× 203 0.5× 134 0.5× 100 2.2k
Carla Vitorino Portugal 28 803 1.3× 955 1.7× 674 1.5× 607 1.5× 233 0.8× 108 2.8k
Daquan Chen China 35 1.3k 2.1× 438 0.8× 961 2.1× 1.0k 2.5× 472 1.6× 121 3.5k
Mahavir B. Chougule United States 26 1.1k 1.9× 927 1.6× 619 1.3× 433 1.1× 160 0.6× 63 2.8k

Countries citing papers authored by Sarika Wairkar

Since Specialization
Citations

This map shows the geographic impact of Sarika Wairkar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarika Wairkar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarika Wairkar more than expected).

Fields of papers citing papers by Sarika Wairkar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarika Wairkar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarika Wairkar. The network helps show where Sarika Wairkar may publish in the future.

Co-authorship network of co-authors of Sarika Wairkar

This figure shows the co-authorship network connecting the top 25 collaborators of Sarika Wairkar. A scholar is included among the top collaborators of Sarika Wairkar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarika Wairkar. Sarika Wairkar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wairkar, Sarika, et al.. (2025). Tofacitinib in focus: Fascinating voyage from conventional formulations to novel delivery systems. International Journal of Pharmaceutics. 671. 125253–125253. 2 indexed citations
2.
Gowda, C.D. Raghavendra, et al.. (2025). Advanced Drug Delivery Systems Utilizing β‐Lactoglobulin: An Efficient Protein‐Based Drug Carrier. Biopolymers. 116(2). e70005–e70005. 1 indexed citations
3.
Wairkar, Sarika, et al.. (2025). EFSA prohibits titanium dioxide in food- should pharmaceuticals be next?. Toxicology. 513. 154089–154089. 1 indexed citations
4.
Mishra, Tejaswini & Sarika Wairkar. (2025). Pathogenesis, attenuation, and treatment strategies for keloid management. Tissue and Cell. 94. 102800–102800. 4 indexed citations
5.
Singh, Alok, et al.. (2024). Brain-targeted nasal chrysin microemulsion for reducing oxidative stress in Parkinson's disease: Pharmacodynamic, biochemical evaluation and brain distribution studies. Journal of Drug Delivery Science and Technology. 97. 105756–105756. 4 indexed citations
6.
Gowda, C.D. Raghavendra & Sarika Wairkar. (2024). Azelaic acid-based lyotropic liquid crystals gel for acne vulgaris: Formulation optimization, antimicrobial activity and dermatopharmacokinetic study. International Journal of Pharmaceutics. 667(Pt A). 124879–124879. 4 indexed citations
7.
Wairkar, Sarika, et al.. (2024). Flavonoids-based delivery systems to treat atopic dermatitis. Journal of Drug Delivery Science and Technology. 98. 105909–105909. 2 indexed citations
8.
9.
Wairkar, Sarika, et al.. (2023). In silico and in vitro investigation of bile salts as coformers for edaravone coamorphous dispersion- Part I. Chemistry and Physics of Lipids. 253. 105302–105302. 4 indexed citations
10.
Wairkar, Sarika, et al.. (2023). Stem cells as a regenerative medicine approach in treatment of microvascular diabetic complications. Tissue and Cell. 85. 102225–102225. 3 indexed citations
11.
Wairkar, Sarika, et al.. (2023). Chitosan and α-cellulose-based mupirocin topical film-forming spray: Optimization, in vitro characterization, antimicrobial studies and wound healing activity. International Journal of Biological Macromolecules. 254(Pt 1). 127622–127622. 9 indexed citations
12.
Prabhakar, Bala, et al.. (2022). Non-oral routes, novel formulations and devices of contraceptives: An update. Journal of Controlled Release. 345. 798–810. 9 indexed citations
13.
Wairkar, Sarika, et al.. (2022). Dietary polyphenols for management of rheumatoid arthritis: Pharmacotherapy and novel delivery systems. Phytotherapy Research. 36(6). 2324–2341. 12 indexed citations
14.
Wairkar, Sarika, et al.. (2022). Folic acid anchored urchin-like raloxifene nanoparticles for receptor targeting in breast cancer: Synthesis, optimisation and in vitro biological evaluation. International Journal of Pharmaceutics. 623. 121926–121926. 12 indexed citations
15.
Wairkar, Sarika, et al.. (2022). Biomimetic fabrication of nanotherapeutics by leukocyte membrane cloaking for targeted therapy. Colloids and Surfaces B Biointerfaces. 219. 112803–112803. 20 indexed citations
16.
Wairkar, Sarika, et al.. (2022). Topical nanocrystals of bioflavonoids: A new technology platform for skin ailments. International Journal of Pharmaceutics. 619. 121707–121707. 13 indexed citations
17.
Wairkar, Sarika, et al.. (2021). Enzyme-responsive smart nanocarriers for targeted chemotherapy: an overview. Drug Delivery and Translational Research. 12(6). 1293–1305. 41 indexed citations
18.
Wairkar, Sarika, et al.. (2019). Recent therapeutic strategies targeting beta amyloid and tauopathies in Alzheimer's disease. Brain Research Bulletin. 146. 171–184. 92 indexed citations
19.
Wairkar, Sarika, et al.. (2019). Recent advances in topical delivery of flavonoids: A review. Journal of Controlled Release. 296. 190–201. 172 indexed citations
20.
Wairkar, Sarika, et al.. (2017). Pramipexole dihydrochloride loaded chitosan nanoparticles for nose to brain delivery: Development, characterization and in vivo anti-Parkinson activity. International Journal of Biological Macromolecules. 109. 27–35. 143 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jie Tang Breakdown of academic impact, for papers by Alam Zeb Breakdown of academic impact, for papers by Khalid M. El‐Say Breakdown of academic impact, for papers by Omer Salman Qureshi Breakdown of academic impact, for papers by Swarnlata Saraf Breakdown of academic impact, for papers by Hidemasa Katsumi Breakdown of academic impact, for papers by Ferenc Fenyvesi Breakdown of academic impact, for papers by Carla Vitorino Breakdown of academic impact, for papers by Daquan Chen Breakdown of academic impact, for papers by Mahavir B. Chougule
Rankless by CCL
2026